Showing results (1071-1080 of 2,922) with videos related to

Sort By:
Pageof 293
Journal of Ethnopharmacology|February 2, 2010
Protective effect of 5-hydroxymethylfurfural derived from processed Fructus Corni on human hepatocyte LO2 injured by hydrogen peroxide and its mechanismXia Ding, Ming-Yan Wang, Yun-Xiang Yao, et al.
Huan Jing Ke Xue= Huanjing Kexue|July 3, 2018
[Effects of Conductivity on Performance of a Combined System of Anaerobic Acidification, Forward Osmosis, and a Microbial Fuel Cell]Yu-Qin Lu, Jin-Meng Liu, Xin-Hua Wang, et al.
Frontiers in Oncology|May 16, 2022
Advances of Patient-Derived Organoids in Personalized RadiotherapyYuenan Wang, Ye Li, Zonghai Sheng, et al.
Journal of Gastrointestinal Oncology|May 13, 2022
Efficacy and safety of transarterial chemoembolization-lenvatinib sequential therapy for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a retrospective studyRuiqing Chen, Ye Li, Ke Song, et al.
Computer Methods and Programs in Biomedicine|May 15, 2022
An accurate and explainable ensemble learning method for carotid plaque prediction in an asymptomatic populationDan Wu, Guosheng Cui, Xiaoxiang Huang, et al.
Oncotargets and Therapy|February 6, 2020
miR-939-5p Contributes to the Migration and Invasion of Pancreatic Cancer by Targeting ARHGAP4Yehua Shen, Gang Chen, Huifeng Gao, et al.
European Radiology|April 2, 2023
Radiomics analysis of lung CT for multidrug resistance prediction in active tuberculosis: a multicentre studyYe Li, Zexuan Xu, Xinna Lv, et al.
European Journal of Radiology|September 1, 2022
Differentiating EGFR from ALK mutation status using radiomics signature based on MR sequences of brain metastasisYe Li, Xinna Lv, Bing Wang, et al.
Cellular Signalling|October 20, 2022
Construction of crizotinib resistant models with CD74-ROS1 D2033N and CD74-ROS1 S1986F point mutations to explore resistance mechanism and treatment strategyRui Sun, Yuting Meng, Rui Xu, et al.
The FEBS Journal|December 27, 2023
CD74-ROS1 L2026M mutant enhances autophagy through the MEK/ERK pathway to promote invasion, metastasis and crizotinib resistance in non-small cell lung cancer cellsXiaobo Xu, Ye Li, Rui Xu, et al.
Pageof 293